Dr. Renfeng Li is an Associate Professor at the Department of Microbiology and Molecular Genetics, University of Pittsburgh. He completed his PhD studies in Biology at Tsinghua University and has been awarded NIH K99/R00 award. The Li lab is focusing on understanding the molecular mechanisms by which viral and host factors control the transition of EBV from latency to reactivation with a goal of developing novel therapeutic strategies to cure EBV-associated cancer.
Research Keywords & Expertise
Sumoylation
Epstein-Barr Virus
ubiquitination
herpesvirus
Tumor virus
Fingerprints
62%
Epstein-Barr Virus
44%
herpesvirus
16%
ubiquitination
13%
Sumoylation
8%
Tumor virus
Short Biography
Dr. Renfeng Li is an Associate Professor at the Department of Microbiology and Molecular Genetics, University of Pittsburgh. He completed his PhD studies in Biology at Tsinghua University and has been awarded NIH K99/R00 award. The Li lab is focusing on understanding the molecular mechanisms by which viral and host factors control the transition of EBV from latency to reactivation with a goal of developing novel therapeutic strategies to cure EBV-associated cancer.